Advisor Group Holdings, Inc. Argenx Se Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Argenx Se stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,066 shares of ARGX stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,066

Previous 1,940 6.49%

Holding current value

$1.21 Million

Previous $1.19 Million 2.43%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$571.0 - $671.75 $71,946 - $84,640	126 Added 6.49%	2,066 $1.22 Million
Q4 2024 Jun 06, 2025	SELL	$520.52 - $638.33 $101,501 - $124,474	-195 Reduced 9.44%	1,871 $1.15 Million
Q4 2024 Feb 07, 2025	BUY	$520.52 - $638.33 $2,082 - $2,553	4 Added 0.21%	1,940 $1.19 Million
Q3 2024 Nov 13, 2024	BUY	$434.22 - $551.9 $587,065 - $746,168	1,352 Added 231.51%	1,936 $1.05 Million
Q2 2024 Aug 13, 2024	BUY	$356.01 - $451.55 $51,621 - $65,474	145 Added 33.03%	584 $251,000
Q1 2024 May 10, 2024	SELL	$356.95 - $413.29 $1.31 Million - $1.52 Million	-3,672 Reduced 89.32%	439 $172,000
Q4 2023 Feb 12, 2024	SELL	$338.91 - $506.01 $270,789 - $404,301	-799 Reduced 16.27%	4,111 $1.56 Million
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $962,156 - $1.43 Million	2,605 Added 113.02%	4,910 $2.41 Million
Q2 2023 Aug 10, 2023	BUY	$360.14 - $422.58 $46,458 - $54,512	129 Added 5.93%	2,305 $898,000
Q1 2023 May 12, 2023	BUY	$334.23 - $403.65 $7,687 - $9,283	23 Added 1.07%	2,176 $810,000
Q4 2022 Feb 10, 2023	SELL	$342.17 - $402.31 $7,185 - $8,448	-21 Reduced 0.97%	2,153 $815,000
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $804,117 - $927,242	-2,343 Reduced 51.87%	2,174 $768,000
Q2 2022 Aug 10, 2022	BUY	$269.58 - $378.88 $794,452 - $1.12 Million	2,947 Added 187.71%	4,517 $1.71 Million
Q1 2022 May 04, 2022	BUY	$254.45 - $351.06 $100,507 - $138,668	395 Added 33.62%	1,570 $495,000
Q3 2021 Nov 05, 2021	BUY	$295.0 - $350.58 $35,400 - $42,069	120 Added 11.37%	1,175 $353,000
Q2 2021 Aug 02, 2021	SELL	$257.11 - $319.92 $184,862 - $230,022	-719 Reduced 40.53%	1,055 $317,000
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $55,269 - $78,343	206 Added 13.14%	1,774 $489,000
Q4 2020 Feb 10, 2021	SELL	$248.13 - $308.36 $7,195 - $8,942	-29 Reduced 1.82%	1,568 $462,000
Q3 2020 Nov 12, 2020	BUY	$215.51 - $272.51 $18,964 - $23,980	88 Added 5.83%	1,597 $420,000
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $26,507 - $48,405	208 Added 15.99%	1,509 $339,000
Q1 2020 May 18, 2020	BUY	$108.83 - $165.23 $141,587 - $214,964	1,301 New	1,301 $171,000

Others Institutions Holding ARGX

# of Institutions

498

Shares Held

28.5M

Call Options Held

330K

Put Options Held

286K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $32.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Argenx Se Transaction History